State Street Corp Cv Rx, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Cv Rx, Inc. stock. As of the latest transaction made, State Street Corp holds 264,733 shares of CVRX stock, worth $3.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

264,733

Previous 237,662 11.39%

Holding current value

$3.68 Million

Previous $2.85 Million 18.15%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.15 - $12.37 $193,557 - $334,868	27,071 Added 11.39%	264,733 $2.33 Million
Q2 2024 Aug 14, 2024	BUY	$6.49 - $19.2 $146,972 - $434,803	22,646 Added 10.53%	237,662 $2.85 Million
Q1 2024 May 15, 2024	BUY	$17.99 - $30.49 $229,534 - $389,021	12,759 Added 6.31%	215,016 $3.92 Million
Q4 2023 Feb 14, 2024	SELL	$11.67 - $33.01 $3.75 Million - $10.6 Million	-321,058 Reduced 61.35%	202,257 $6.36 Million
Q3 2023 Nov 14, 2023	BUY	$13.56 - $18.47 $178,585 - $243,249	13,170 Added 2.58%	523,315 $7.94 Million
Q2 2023 Aug 14, 2023	BUY	$8.57 - $15.44 $4.01 Million - $7.23 Million	468,269 Added 1118.23%	510,145 $7.88 Million
Q1 2023 May 15, 2023	BUY	$7.08 - $19.4 $51,684 - $141,620	7,300 Added 21.11%	41,876 $390,000
Q4 2022 Feb 14, 2023	BUY	$8.94 - $18.35 $92,341 - $189,537	10,329 Added 42.6%	34,576 $634,000
Q2 2022 Aug 15, 2022	SELL	$4.7 - $7.22 $1.05 Million - $1.61 Million	-223,409 Reduced 90.21%	24,247 $146,000
Q1 2022 May 16, 2022	BUY	$5.62 - $12.37 $56,739 - $124,887	10,096 Added 4.25%	247,656 $1.48 Million
Q4 2021 Feb 14, 2022	BUY	$10.65 - $18.61 $1.6 Million - $2.8 Million	150,317 Added 172.3%	237,560 $2.91 Million
Q3 2021 Nov 15, 2021	BUY	$14.65 - $26.07 $1.28 Million - $2.27 Million	87,243 New	87,243 $1.44 Million

Others Institutions Holding CVRX

# of Institutions

Shares Held

14.4M

Call Options Held

56.3K

Put Options Held

41.8K

View Full List

About CVRx, Inc.

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $286M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

More about CVRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Cv Rx, Inc. Transaction History